NEW YORK (GenomeWeb) — Cepheid reported after the close of the market Thursday a 21 percent increase in second quarter revenues as it placed a record number of GeneXpert diagnostic systems during the period.

For the three months ended June 30, Cepheid logged revenues of $116.5 million compared to $96.0 million in Q2 2014, narrowly beating the average Wall Street estimate of $115.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.